{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:04:26Z","timestamp":1782601466405,"version":"3.54.5"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/cco.0000000000000249","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T15:30:49Z","timestamp":1448119849000},"page":"5-10","source":"Crossref","is-referenced-by-count":41,"title":["Pheochromocytoma and paraganglioma"],"prefix":"10.1097","volume":"28","author":[{"given":"Nelly","family":"Burnichon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"e86756","DOI":"10.1371\/journal.pone.0086756","article-title":"Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.","volume":"9","author":"Crona","year":"2014","journal-title":"PLoS One"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multiomics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11912-013-0320-x","article-title":"Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.","volume":"15","author":"Jimenez","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.","volume":"171","author":"Baudin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma.","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3.","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.","volume":"43","author":"Comino-Mendez","year":"2011","journal-title":"Nat Genet"},{"key":"R13-3-20210128","first-page":"053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.","volume":"107djv","author":"Cascon","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.","volume":"24","author":"Lopez-Jimenez","year":"2010","journal-title":"Mol Endocrinol"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma.","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/ERC-12-0183","article-title":"Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.","volume":"20","author":"de Cubas","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","article-title":"DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers.","volume":"21","author":"de Cubas","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-3-20210128","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal andor malignant phaeochromocytomas.","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","article-title":"SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.","volume":"266","author":"Pasini","year":"2009","journal-title":"J Intern Med"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma.","volume":"99","author":"Clark","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.","volume":"22","author":"Comino-Mendez","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0384","article-title":"Frequent EPAS1HIF2alpha exons 9 and 12 mutations in nonfamilial pheochromocytoma.","volume":"21","author":"Welander","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome.","volume":"99","author":"Buffet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/hmg\/dds374","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.","volume":"21","author":"Burnichon","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas.","volume":"21","author":"Welander","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma.","volume":"23","author":"Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.","volume":"98","author":"Crona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"138573","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int J Endocrinol"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.","volume":"52","author":"Curras-Freixes","year":"2015","journal-title":"J Med Genet"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","article-title":"The genomic landscape of phaeochromocytoma.","volume":"236","author":"Flynn","year":"2015","journal-title":"J Pathol"},{"key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/ERC-13-0429","article-title":"Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.","volume":"21","author":"Papathomas","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"E1392","DOI":"10.1210\/jc.2013-4536","article-title":"Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation.","volume":"99","author":"Casey","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1530\/EC-13-0009","article-title":"Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma.","volume":"2","author":"Crona","year":"2013","journal-title":"Endocr Connect"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","article-title":"A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.","volume":"98","author":"Rattenberry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.","volume":"99","author":"Welander","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MED.0000000000000150","article-title":"Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes.","volume":"22","author":"Toledo","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-14-2854","article-title":"Spatio-temporal heterogeneity characterizes the genetic landscape of pheochromocytoma and defines early events in tumourigenesis.","volume":"21","author":"Crona","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:58:37Z","timestamp":1620950317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201601000-00003"}},"subtitle":["molecular testing and personalized medicine"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000249","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}